mango
Senior Member (Voting Rights)
Post-Covid-19 Tachycardia Syndrome: A distinct phenotype of Post-acute Covid-19 Syndrome
Ståhlberg, Fedorowski et al
Abstract
In this paper we highlight the presence of tachycardia in Post-acute Covid-19 Syndrome by introducing a new label for this phenomenon: Post-covid-19 tachycardia syndrome and argue that this constitutes a phenotype or sub-syndrome in PACS. We also discuss epidemiology, putative mechanisms, treatment options and future research directions in this novel clinical syndrome.
Highlights (Clinical Significance)
Ståhlberg, Fedorowski et al
Abstract
In this paper we highlight the presence of tachycardia in Post-acute Covid-19 Syndrome by introducing a new label for this phenomenon: Post-covid-19 tachycardia syndrome and argue that this constitutes a phenotype or sub-syndrome in PACS. We also discuss epidemiology, putative mechanisms, treatment options and future research directions in this novel clinical syndrome.
Highlights (Clinical Significance)
- Post-acute covid-19 syndrome is a novel clinical syndrome with symptoms beyond 4-12 weeks after a SARS-CoV-2 infection
- Tachycardia is commonly reported in these patients and may be considered a distinct phenotype
- Putative mechanism for tachycardia in this setting include dysautonomia
- Post-acute covid-19 syndrome patients reporting palpitations should be subjected to basic cardiovascular evaluation (including head-up TILT testing if concomitant orthostatic intolerance)
- Treatment options include cardiovascular drugs and structured rehabilitation program